Skip to main content
. 2017 Jun 5;12(6):e0178593. doi: 10.1371/journal.pone.0178593

Table 7. Toxicity summary.

Any Grade Grade 3 or 4
Hematologic Adverse Events No. % No. %
Decreased leukocytes 11 47.83% 0 0.00%
Decreased hemoglobin 10 43.48% 0 0.00%
Decreased neutrophils 6 26.09% 2 8.70%
Decreased platelets 5 21.74% 0 0.00%
Lymphopenia 4 17.39% 0 0.00%
Non-hematologic Adverse Events
Fatigue 15 65.22% 1 4.35%
Nausea 15 65.22% 0 0.00%
Hyperglycemia 14 60.87% 1 4.35%
Vomiting 13 56.52% 0 0.00%
Diarrhea 10 43.48% 0 0.00%
ALT 9 39.13% 0 0.00%
Anorexia 7 30.43% 0 0.00%
AST 6 26.09% 0 0.00%
Fever 5 21.74% 1 4.35%
Hypocalcemia 5 21.74% 0 0.00%
Hypokalemia 5 21.74% 0 0.00%
Hyponatremia 5 21.74% 0 0.00%
Pain—abdomen NOS 5 21.74% 0 0.00%
Infection URI 4 17.39% 0 0.00%
Constipation 3 13.04% 0 0.00%
Flatulence 3 13.04% 0 0.00%
Hypomagnesemia 3 13.04% 0 0.00%
Hypophosphatemia 3 13.04% 0 0.00%
Pain—stomach 3 13.04% 0 0.00%
Hyperuricemia 1 4.35% 1 4.35%
Infection—catheter related 1 4.35% 1 4.35%

Notes: Toxicities considered to be at least possibly related. Non-hematological toxicities seen in either > 10% of subjects or ≥ grade 3.